Search results
Swiss biotech Melodia sings $275M song for Alivexis’ preclinical cathepsin C inhibitor
FierceBiotech· 3 days agoSwitzerland’s Melodia Therapeutics has signed a $275 million biobucks deal to get its hands on...
Innovent Reports Oncology Pipeline Updates at Investor Meeting
Morningstar· 6 days agoSAN FRANCISCO and SUZHOU, China, June 18, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes ...
War in Europe is waking CEOs up from their 'geopolitical nap'
Fortune· 4 days agoThe Boston-based group launched its Center for Geopolitics this week, which Lang will chair. “Most people who are in leadership positions today always operated in an environment where geopolitics ...
Chutes & Ladders—Third Rock's cardiometabolic biotech unveils C-suite
FierceBiotech· 3 days agoPlease send the good word—or the bad—from your shop to Gabrielle Masson and it will be featured here...